Prophylactic transfusion for pregnant women with sickle cell disease: A systematic review and meta-analysis

Blood

Volumn 126, Issue 21, 2015, Pages 2424-2435

  Malinowski, Ann Kinga ^a,b   Shehata, Nadine ^a,b,c,d   D'Souza, Rohan ^a,b   Kuo, Kevin H M ^b,d   Ward, Richard ^b,d   Shah, Prakesh S ^a,b,c   Murphy, Kellie ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COHORT ANALYSIS; DATA BASE; ERYTHROCYTE TRANSFUSION; FEMALE; HIGH RISK PATIENT; HUMAN; LUNG EMBOLISM; MATERNAL MORTALITY; META ANALYSIS; NEWBORN DEATH; OUTCOME ASSESSMENT; PERINATAL MORTALITY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROPHYLAXIS; PYELONEPHRITIS; SICKLE CELL ANEMIA; SYSTEMATIC REVIEW; ANEMIA, SICKLE CELL; LUNG DISEASES; MORTALITY; PAIN; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

ANEMIA, SICKLE CELL; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; LUNG DISEASES; MATERNAL MORTALITY; PAIN; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 84948989519     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-06-649319     Document Type: Article

References (45)

1. Malowany JI, Butany J. Pathology of sickle cell disease. Semin Diagn Pathol. 2012;29(1):49-55.
2. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-2128.
3. Oteng-Ntim E, Chase AR, Howard J, Khazaezadeh N, Anionwu EN. Sickle cell disease in pregnancy. Obstetrics Gynaecol Reprod Med. 2008;18(10):272-278.
4. Hassell K. Pregnancy and sickle cell disease. Hematol Oncol Clin North Am. 2005;19(5):903-916.
5. Fort AT, Morrison JC, Diggs LW, Fish SA, Berreras L. Counseling the patient with sickle cell disease about reproduction: pregnancy outcome does not justify the maternal risk. Am J Obstet Gynecol. 1971;111(3):324-327.
6. Afolabi BB, Iwuala NC, Iwuala IC, Ogedengbe OK. Morbidity and mortality in sickle cell pregnancies in Lagos, Nigeria: a case control study. J Obstet Gynaecol. 2009;29(2):104-106.
7. Al Kahtani MA, AlQahtani M, Alshebaily MM, Abd Elzaher M, Moawad A, Aljohani N. Morbidity and pregnancy outcomes associated with sickle cell anemia among Saudi women. Int J Gynaecol Obstet. 2012;119(3):224-226.
8. Villers MS, Jamison MG, De Castro LM, James AH. Morbidity associated with sickle cell disease in pregnancy. Am J Obstet Gynecol. 2008;199(2): e121-e125.
9. Oteng-Ntim E, Meeks D, Seed PT, et al. Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis. Blood. 2015;125(21):3316-3325.
10. Howard RJ, Tuck SM, Pearson TC. Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome. Br J Obstet Gynaecol. 1995;102(12):947-951.
11. Ware RE, Helms RW, Investigators SW; SWiTCH Investigators. Stroke with transfusions changing to hydroxyurea (SWiTCH). Blood. 2012;119(17):3925-3932.
12. Howard J, Malfroy M, Llewelyn C, et al. The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial. Lancet. 2013; 381(9870):930-938.
13. Chou ST. Transfusion therapy for sickle cell disease: a balancing act. Hematology Am Soc Hematol Educ Program. 2013;2013:439-446.
14. Asma S, Kozanoglu I, Tarim E, et al. Prophylactic red blood cell exchange may be beneficial in the management of sickle cell disease in pregnancy. Transfusion. 2015;55(1):36-44.
15. Koshy M, Chisum D, Burd L, Orlina A, How H. Management of sickle cell anemia and pregnancy. J Clin Apher. 1991;6(4):230-233.
16. Erratum appears in J Clin Apheresis 1992;7(4):221
17. Koshy M, Burd L, Wallace D, Moawad A, Baron J. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study. N Engl J Med. 1988;319(22):1447-1452.
18. Gilli SC, De Paula EV, Biscaro FP, Marques JF, Costa FF, Saad ST. Third-trimester erythrocytapheresis in pregnant patients with sickle cell disease. Int J Gynaecol Obstet. 2007; 96(1):8-11.
19. El-Shafei AM, Kaur Dhaliwal J, Kaur Sandhu A, Rashid Al-Sharqi M. Indications for blood transfusion in pregnancy with sickle cell disease. Aust N Z J Obstet Gynaecol. 1995;35(4):405-408.
20. Cunningham FG, Pritchard JA, Mason R. Pregnancy and sickle cell hemoglobinopathies: results with and without prophylactic transfusions. Obstet Gynecol. 1983;62(4):419-424.
21. Moher D, Liberati A, TetzlaffJ, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-269.
22. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283(15):2008-2012.
23. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
24. Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. http://www.ohri.ca/programs/ clinical-epidemiology/oxford.asp. Accessed 23 September 2015.
25. Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011;342: d549.
26. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
27. Miller JM Jr, Horger EO III, Key TC, Walker EM Jr. Management of sickle hemoglobinopathies in pregnant patients. Am J Obstet Gynecol. 1981; 141(3):237-241.
28. Morrison JC, Morrison FS, Floyd RC, Roberts WE, Hess LW, Wiser WL. Use of continuous flow erythrocytapheresis in pregnant patients with sickle cell disease. J Clin Apher. 1991;6(4):224-229.
29. Morrison JC, Wiser WL. The use of prophylactic partial exchange tranfusion in pregnancies associated with sickle cell hemoglobinopathies. Obstet Gynecol. 1976;48(5):516-520.
30. Moussaoui DR, Chouhou L, Guelzim K, Kouach J, Dehayni M, Fehri HS. [Severe sickle cell disease and pregnancy. Systematic prophylactic transfusions in 16 cases]. Med Trop (Mars). 2002; 62(6):603-606.
31. Tuck SM, James CE, Brewster EM, Pearson TC, Studd JW. Prophylactic blood transfusion in maternal sickle cell syndromes. Br J Obstet Gynaecol. 1987;94(2):121-125.
32. Okusanya BO, Oladapo OT. Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy. Cochrane Database Syst Rev. 2013;12: CD010378.
33. Marouf R. Blood transfusion in sickle cell disease. Hemoglobin. 2011;35(5-6):495-502.
34. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018-2031.
35. Telen MJ. Principles and problems of transfusion in sickle cell disease. Semin Hematol. 2001;38(4):315-323.
36. Fasano RM, Booth GS, Miles M, et al. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease. Br J Haematol. 2015;168(2):291-300.
37. Lausman A, Kingdom J, Gagnon R, et al; Maternal Fetal Medicine Committee. Intrauterine growth restriction: screening, diagnosis, and management. J Obstet Gynaecol Can. 2013; 35(8):741-757.
38. Thame M, Lewis J, Trotman H, Hambleton I, Serjeant G. The mechanisms of low birth weight in infants of mothers with homozygous sickle cell disease. Pediatrics. 2007;120(3): e686-e693.
39. Rathod KB, Jaiswal KN, Shrivastava AC, Shrikhande AV. Study of placenta in sickle cell disorders. Indian J Pathol Microbiol. 2007;50(4):698-701.
40. Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 1998;91(10):3527-3561.
41. Decastel M, Leborgne-Samuel Y, Alexandre L, Merault G, Berchel C. Morphological features of the human umbilical vein in normal, sickle cell trait, and sickle cell disease pregnancies. Hum Pathol. 1999;30(1):13-20.
42. Ye L, Chang JC, Lu R, Kan YW. High oxygen environment during pregnancy rescues sickle cell anemia mice from prenatal death. Blood Cells Mol Dis. 2008;41(1):67-72.
43. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51(4):970-975.
44. Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a metaanalysis. Obstet Gynecol. 2010;116(2 Pt 1):402-414.
45. Koshy M, Burd L, Dorn L, HuffG. Frequency of pain crisis during pregnancy. Prog Clin Biol Res. 1987;240:305-311.